Thrivent Financial for Lutherans’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,749	Closed	-$164K	–	2582
2024 Q2	$164K	Buy	+6,749	New	+$164K	﹤0.01%	2498
2023 Q2	–	Sell	-7,417	Closed	-$1.09M	–	2522
2023 Q1	$1.09M	Hold	7,417	–	–	﹤0.01%	1734
2022 Q4	$1.17M	Buy	+7,417	New	+$1.17M	﹤0.01%	1621